Dashboard
Manage Tickers

ECORelectroCore, Inc.

Nasdaq electrocore.com


$ 7.17 $ -0.07 (-0.94 %)    

Thursday, 09-May-2024 09:50:16 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 441.33 $ 0.96 (0.22 %)
DIA $ 394.43 $ 3.52 (0.9 %)
SPY $ 520.56 $ 2.98 (0.58 %)
TLT $ 90.69 $ 0.44 (0.49 %)
GLD $ 216.93 $ 3.37 (1.58 %)
$ 6.85
$ 7.17
$ 0.00 x 0
$ 0.00 x 0
$ 7.17 - $ 7.17
$ 3.83 - $ 8.08
33,350
na
47.89M
$ 0.79
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 03-13-2024 12-31-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-03-2023 03-31-2023 10-Q
6 03-08-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 03-10-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-05-2021 06-30-2021 10-Q
13 05-06-2021 03-31-2021 10-Q
14 03-11-2021 12-31-2020 10-K
15 11-12-2020 09-30-2020 10-Q
16 08-13-2020 06-30-2020 10-Q
17 05-15-2020 03-31-2020 10-Q
18 03-30-2020 12-31-2019 10-K
19 11-14-2019 09-30-2019 10-Q
20 08-14-2019 06-30-2019 10-Q
21 05-15-2019 03-31-2019 10-Q
22 03-28-2019 12-31-2018 10-K
23 11-14-2018 09-30-2018 10-Q
24 08-14-2018 06-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

electrocore-q1-2024-gaap-eps-053-beats-061-estimate-sales-5443m-beat-4767m-estimate
electroCore Q1 2024 GAAP EPS $(0.53) Beats...
05/08/2024 20:58:52

electroCore (NASDAQ:ECOR) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(0.61) b...

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
05/08/2024 20:31:13

electrocore-launches-truvaga-plus-for-general-wellness
electroCore Launches Truvaga Plus For Gene...
04/08/2024 12:44:01

electrocore-expands-intellectual-property-portfolio-with-two-new-patents-no-11944815-and-no-11944807
electroCore Expands Intellectual Property ...
04/02/2024 12:18:47

electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it has re...

hc-wainwright--co-reiterates-buy-on-electrocore-maintains-15-price-target
HC Wainwright & Co. Reiterates Buy on elec...
03/14/2024 10:52:15

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates electroCore (NASDAQ:ECOR) with a Buy and maintains $15 pri...

electrocore-q4-2023-gaap-eps-061-inline-sales-5191m-beat-4967m-estimate
electroCore Q4 2023 GAAP EPS $(0.61), Inli...
03/13/2024 20:07:55

electroCore (NASDAQ:ECOR) reported quarterly losses of $(0.61) per share which met the analyst consensus estimate. The company...

earnings-scheduled-for-march-13-2024
Earnings Scheduled For March 13, 2024
03/13/2024 10:15:56

Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share...

a-preview-of-electrocores-earnings
A Preview Of electroCore's Earnings
03/12/2024 17:01:00

electrocore-expands-intellectual-property-portfolio-with-us-patent-no-11894148-entitled-systems-and-methods-for-treating-patients-with-diseases-associated-with-viruses
electroCore Expands Intellectual Property ...
02/06/2024 13:11:56

electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the United Sta...

hc-wainwright--co-maintains-buy-on-electrocore-raises-price-target-to-15
HC Wainwright & Co. Maintains Buy on elect...
01/22/2024 12:33:13

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains electroCore (NASDAQ:ECOR) with a Buy and raises the price t...

electrocore-expands-intellectual-property-portfolio-trademark-office-has-issued-a-patent-related-to-systems-and-methods-for-treating-post-traumatic-stress-disorder
electroCore Expands Intellectual Property ...
01/09/2024 13:10:41

electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the United Sta...

electrocore-expands-intellectual-property-portfolio-the-two-patents-were-issued-on-december-26-2023-and-relate-to-electrocores-non-invasive-vagus-nerve-stimulation-technology
electroCore Expands Intellectual Property ...
12/26/2023 13:04:35

electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it has re...

electrocore-announced-the-us-patent-and-trademark-office-has-issued-a-patent-related-to-a-system-for-stimulating-a-nerve-target-in-the-head-or-neck-of-a-patient-for-treatment-of-various-disorders-such-as-primary-headache
electroCore, Announced The U.S. Patent And...
12/12/2023 13:06:02

U.S. Patent No. 11,839,764 entitled "Systems and Methods for Treating a Medical Condition with an Electrical Stimulation Tr...

hc-wainwright--co-maintains-buy-on-electrocore-raises-price-target-to-11
HC Wainwright & Co. Maintains Buy on elect...
11/09/2023 12:24:29

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains electroCore (NASDAQ:ECOR) with a Buy and raises the price t...

electrocore-sees-fy23-revenue-15m-155m-vs-1443m-est
ElectroCore Sees FY23 Revenue $15M-$15.5M ...
11/08/2023 23:07:56

electrocore-q3-eps-068-up-from-120-yoy-sales-451m-up-from-198m-yoy
electroCore Q3 EPS $(0.68) Up From $(1.20)...
11/08/2023 21:44:57

electroCore (NASDAQ:ECOR) reported quarterly losses of $(0.68) per share. This is a 43.33 percent increase over losses of $(1.2...

earnings-scheduled-for-november-8-2023
Earnings Scheduled For November 8, 2023
11/08/2023 09:21:00

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.

electrocores-gammacore-therapy-will-continue-to-be-listed-in-the-uks-national-health-service-supply-chain-catalogue-for-additional-two-years-till-march-17-2026-the-listing-commenced-on-june-4-2019-was-scheduled-to-terminate-on-march-18-2024
ElectroCore's GammaCore Therapy Will Conti...
10/17/2023 12:03:56

electrocore-inc-announces-data-highlighting-non-invasive-vagus-nerve-stimulation-for-treatment-of-acute-neurological-injury-presented-at-2023-world-stroke-congress
electroCore, Inc. Announces Data Highlight...
10/10/2023 12:03:58

"VANQUISH" Clinical Trial (n=40) suggests safety and efficacy of nVNS for the Treatment of Headache Associated with Sub...

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
09/05/2023 13:06:06

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION